Literature DB >> 25498673

Thiolated nanocarriers for oral delivery of hydrophilic macromolecular drugs.

S Dünnhaupt1, J Barthelmes1, S Köllner1, D Sakloetsakun2, G Shahnaz3, A Düregger4, A Bernkop-Schnürch5.   

Abstract

It was the aim of this study to investigate the effect of unmodified as well as thiolated anionic poly(acrylic acid) (PAA) and cationic chitosan (CS) utilized in free-soluble form and as nanoparticulate system on the absorption of the hydrophilic compound FD4 across intestinal epithelial cell layer with and without a mucus layer. Modifications of these polymers were achieved by conjugation with cysteine to PAA (PAA-Cys) and thioglycolic acid to CS (CS-TGA). Particles were prepared via ionic gelation and characterized based on their amount of thiol groups, particle size and zeta potential. Effects on the cell layer concerning absorption enhancement, transepithelial electrical resistance (TEER) and cytotoxicity were investigated. Permeation enhancement was evaluated with respect to in vitro transport of FD4 across Caco-2 cells, while mucoadhesion was indirectly examined in terms of adsorption behaviour when cells were covered with a mucus layer. Lyophilized particles displayed around 1000 μmol/g of free thiol groups, particle sizes of less than 300 nm and a zeta potential of 18 mV (CS-TGA) and -14 mV (PAA-Cys). Cytotoxicity studies confirmed that all polymer samples were used at nontoxic concentrations (0.5% m/v). Permeation studies revealed that all thiolated formulations had pronounced effects on the paracellular permeability of mucus-free Caco-2 layers and enhanced the permeation of FD4 3.0- to 5.3-fold. Moreover, polymers administered as particles showed a higher permeation enhancement than their corresponding solutions. However, the absorption-enhancing effect of each thiolated formulation was significantly (p<0.05) reduced when cells were covered with mucus layer. In addition, all formulations were able to decrease the TEER of the cell layer significantly (p<0.05). Therefore, both thiolated polymers as nanoparticulate delivery systems represent a promising tool for the oral administration of hydrophilic macromolecules.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adhesion; Chitosan (PubChem CID: CID 21896651); Cytotoxic effects; Dithionitrobenzoic acid (PubChem CID: 6254); Nanoparticles; Permeation enhancement; Polymer synthesis; Sodium borohydride (PubChem CID: 22959485); Thiazolyl blue tetrazolium bromide (MTT) (PubChem CID: 64965); Thioglycolic acid (PubChem CID: 1133); l-Cysteine hydrochloride (PubChem CID: 60960)

Mesh:

Substances:

Year:  2014        PMID: 25498673     DOI: 10.1016/j.carbpol.2014.09.078

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  5 in total

Review 1.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

2.  Thiolation of arabinoxylan and its application in the fabrication of controlled release mucoadhesive oral films.

Authors:  Muhammad Hanif; Muhammad Zaman
Journal:  Daru       Date:  2017-03-20       Impact factor: 3.117

Review 3.  Strategies for the enhanced intracellular delivery of nanomaterials.

Authors:  Cláudia Azevedo; Maria Helena Macedo; Bruno Sarmento
Journal:  Drug Discov Today       Date:  2017-09-15       Impact factor: 7.851

Review 4.  Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.

Authors:  Nathalie Hock; Giuseppe Francesco Racaniello; Sam Aspinall; Nunzio Denora; Vitaliy V Khutoryanskiy; Andreas Bernkop-Schnürch
Journal:  Adv Sci (Weinh)       Date:  2021-11-12       Impact factor: 16.806

Review 5.  Thiolated-Polymer-Based Nanoparticles as an Avant-Garde Approach for Anticancer Therapies-Reviewing Thiomers from Chitosan and Hyaluronic Acid.

Authors:  Roberto Grosso; M-Violante de-Paz
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.